A placebo double-blind pilot study of dextromethorphan for problematic behaviors in children with autism

Autism

Volumn 11, Issue 1, 2007, Pages 29-41

  Woodard, Cooper ^a   Groden, June ^a   Goodwin, Matthew ^a   Bodfish, James ^b  

^a Groden Network   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Autism; Dextromethorphan; Treatment

Indexed keywords

DELSYN; DEXTROMETHORPHAN; PLACEBO;

ADOLESCENT; AGGRESSION; AGITATION; ANGER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; DECREASED APPETITE; DEFECATION; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; EXCITEMENT; FEMALE; HEADACHE; HUMAN; IRRITABILITY; MALE; MENTAL DEFICIENCY; NAUSEA AND VOMITING; NOSE CONGESTION; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RESTLESSNESS; SCHOOL CHILD; SIDE EFFECT; SKIN DISEASE; SLEEP DISORDER; SYMPTOMATOLOGY; TREATMENT RESPONSE; WEIGHT GAIN;

ADOLESCENT; ADOLESCENT BEHAVIOR; ANALGESICS, OPIOID; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; CHILD BEHAVIOR DISORDERS; DEXTROMETHORPHAN; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; IRRITABLE MOOD; MALE; PILOT PROJECTS; PLACEBOS; TREATMENT OUTCOME;

EID: 33845509491     PISSN: 13623613     EISSN: 14617005     Source Type: Journal    
DOI: 10.1177/1362361307070989     Document Type: Article

References (17)

1. AMAN, M.G., SINGH, N.N., STEWART, A.W. & FIELD, C.J. (1985) 'The Aberrant Behavior Checklist: A Behavior Rating Scale for the Assessment of Treatment Effects', American Journal on Mental Deficiency 89: 485-491.
2. CARLSSON, M.L. (1998) 'Hypothesis: Is Infantile Autism a Hypoglutamatergic Disorder? Relevance of Glutamate-Serotonin Interactions for Pharmacotherapy', Journal of Neural Transmission 105: 525-535.
3. HINSBERGER, A., SHARMA, V. & MAZMANIAN, D. (1994) 'Cognitive Deterioration from Long-Term Abuse of Dextromethorphan: A Case Report', Journal of Psychiatry & Neuroscience 19: 375-377.
4. LIU, Y., QIN, L., LI, G., ZHANG, W., AN, L., LIU, B. & HONG, J.S. (2003) 'Dextromethorphan Protects Dopaminergic Neurons against Inflammation-Mediated Degeneration through Inhibition of Microglial Activation', Journal of Pharmacology and Experimental Therapeutics 305 (1): 212-218.
5. LORD, C., RUTTER, M. & LE COUTEUR, A. (1994) 'Autism Diagnostic Interview-Revised: A Revised Version of a Diagnostic Interview for Caregivers of Individuals with Possible Pervasive Developmental Disorders', Journal of Autism and Developmental Disorders 24 (5): 659-685.
6. MCDOUGLE, C.J. (2002) 'Current and Emerging Therapeutics of Autistic Disorder and Related Pervasive Developmental Disorders', in K.L. DAVIS, D. CHARNEY, J.T. COYLE & C. NEMEROFF (eds) Neuropsychopharmacology: The Fifth Generation of Progress, pp. 566-577. Philadelphia: Lippincott Williams and Wilkins.
7. NATIONAL INSTITUTE OF MENTAL HEALTH (1985) 'CGI (Clinical Global Impression) Scale', Psychopharmacology Bulletin (21): 839-843.
8. PALMER, G.C. (2001) 'Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies', Current Drug Targets 2 (3): 241-271.
9. PHILLIPS, J.A., HAMID, R. & MCGREW, S. (1999) 'Effects of Dextromethorphan in Autistic Children with Abnormal Amino Acid Profiles', program 2861, presented at the Annual Meeting of the American Society of Human Genetics (ASHG), San Francisco, CA.
10. POSEY, D.J., KEM, D.L., SWEIZY, N.B., SWEETEN, T.L., WEIGAND, R.E. & M C DOUGLE, C.J. (2004) 'A Pilot Study of D-Cycloserine in Subjects with Autistic Disorder', American Journal of Psychiatry 161: 2115-2117.
11. RAPOPORT, J.L., CONNERS, C.K. & REATIG, N. (eds) (1985) 'Rating Scales and Assessment Instruments for Use in Pediatric Psychopharmacology Research', Psychopharmacology Bulletin 21: 1073-1075.
12. SANDLER, A.D. & BODFISH, J.W. (2000) 'Placebo Effects in Autism: Lessons from Secretin', Journal of Developmental Behavioral Pediatrics 21: 347-350.
13. SANDLER, A.D., SUTTON, K.A., DEWEESE, J., GIRARDI, M.A., SHEPPARD, V. & BODFISH, J.W. (1999) 'Lack of Benefit of a Single Dose of Synthetic Human Secretin in the Treatment of Autism and Pervasive Developmental Disorder', New England Journal of Medicine 341 (24): 1801-1806.
14. SCHOPLER, E., REICHLER, R.J. & RENNER, B.R. (1986) The Childhood Autism Rating Scale for Diagnostic Screening and Classification in Autism. New York: Irvington.
15. SCHWARTZ, R.H. (2005) 'Adolescent Abuse of Dextromethorphan', Clinical Pediatrics 44: 565-568.
16. WELCH, L. & SOVNER, R. (1992) 'The Treatment of a Chronic Organic Mental Disorder with Dextromethorphan in a Man with Severe Mental Retardation', British Journal of Psychiatry 161: 118-120.
17. WOODARD, C.R., GRODEN, J., GOODWIN, M., SHANOWER, C. & BIANCO, J. (2005) 'The Treatment of the Behavioral Sequelae of Autism with Dextromethorphan: A Case Report', Journal of Autism and Developmental Disorders 35: 515-518.